Two children with a rare genetic condition will live very different lives because one was tested at birth and the other was not, their parents say. Marley, five, and Meadow, four months, both have ...
A bench of justices, Anil Kshetarpal and Harish Vaidyanathan Shankar said the judge’s approach undermined judicial conscience ...
Maharishi College Road in Bhubaneswar is undergoing a complete overhaul using Stone Matrix Asphalt (SMA) technology, a first for an entire city stretch. This high-performance mix promises enhanced ...
XRP is back in the spotlight as traders watch for a possible push toward the long-discussed $6 target, fuelled by fresh ETF ...
The domestic stock markets consolidated after reaching all-time highs. The Nifty 50 started at 26,237.45, while the Sensex ...
The Ethereum price surged 10% in the past week as Tom Lee’s BitMine bought another $44M ETH at an average price of $3,033.
Unresolved compliance issues at a manufacturing plant operated by Novo Nordisk have led to a complete response letter for Scholar Rock's lead drug for spinal muscular atrophy (SMA). The CRL is related ...
SCHAUMBURG, Ill., Nov. 26, 2025 /PRNewswire/ -- Cure SMA, the leading nonprofit organization dedicated to supporting those impacted by spinal muscular atrophy (SMA), welcomes the FDA approval of ...
The FDA has approved Itvisma for the treatment of children two years and older, teens and adults living with spinal muscular ...
In today’s Pharma Pulse, the federal government prepares to unveil newly negotiated Medicare prices for 15 high-cost drugs, ...
Now, it’s worth noting Stock Advisor’s total average return is 1,002% — a market-crushing outperformance compared to 190 % ...
The U.S. Food and Drug Administration has approved Novartis' gene therapy for patients with a rare muscle disorder, the drugmaker said on Monday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback